These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33884654)

  • 41. [Experimental study on IL-2- and IL-15 application in allogeneic hematopoietic stem cell transplantation].
    Chen GH; Wu DP; Sun AN; Yang MZ; Wang Y; Tang XW; Chang HR; Feng YF; Zhu ZL
    Zhonghua Xue Ye Xue Za Zhi; 2008 Aug; 29(8):526-30. PubMed ID: 19112915
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Natural Killer Cell Expansion with Autologous Feeder Layer and Anti-CD3 Antibody for Immune Cell Therapy of Hepatocellular Carcinoma.
    Hosseinzadeh F; Ai J; Ebrahimi-Barough S; Seyhoun I; Hajifathali A; Muhammadnejad S; Hosseinzadeh F; Shadnoush M; Dabiri Oskouei F; Verdi J
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3797-3803. PubMed ID: 31870124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD3+ T cells in severe combined immunodeficiency (SCID) mice. V. Allogeneic T cells engrafted into SCID mice do not induce graft-versus-host disease in spite of the absence of host veto and natural suppressor cell activity.
    Tscherning T; Rudolphi A; Reimann J; Claesson MH
    Scand J Immunol; 1991 Dec; 34(6):795-801. PubMed ID: 1836277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The anti-canine distemper virus activities of ex vivo-expanded canine natural killer cells.
    Park JY; Shin DJ; Lee SH; Lee JJ; Suh GH; Cho D; Kim SK
    Vet Microbiol; 2015 Apr; 176(3-4):239-49. PubMed ID: 25680810
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A role for CD2 antibodies (BTI-322 and its humanized form) in the in vivo elimination of human T lymphocytes infiltrating an allogeneic human skin graft in SCID mice: an Fcgamma receptor-related mechanism involving co-injected human NK cells.
    Snanoudj R; Rouleau M; Bidère N; Carmona S; Baron C; Latinne D; Bazin H; Charpentier B; Senik A
    Transplantation; 2004 Jul; 78(1):50-8. PubMed ID: 15257038
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation of recombinant canine interleukin-15 and evaluation of its effects on the proliferation and function of canine NK cells.
    Lee SH; Shin DJ; Kim SK
    Vet Immunol Immunopathol; 2015 May; 165(1-2):1-13. PubMed ID: 25890849
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Shaping of CD56
    Ni M; Wang L; Yang M; Neuber B; Sellner L; Hückelhoven-Krauss A; Schubert ML; Luft T; Hegenbart U; Schönland S; Wuchter P; Chen BA; Eckstein V; Krüger W; Yerushalmi R; Beider K; Nagler A; Müller-Tidow C; Dreger P; Schmitt M; Schmitt A
    Front Immunol; 2019; 10():547. PubMed ID: 30949182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation.
    Shaffer BC; Le Luduec JB; Forlenza C; Jakubowski AA; Perales MA; Young JW; Hsu KC
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):705-709. PubMed ID: 26772158
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infusion of ex-vivo expanded human TCR-αβ
    Achita P; Dervovic D; Ly D; Lee JB; Haug T; Joe B; Hirano N; Zhang L
    Clin Exp Immunol; 2018 Sep; 193(3):386-399. PubMed ID: 30066399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation.
    Shah NN; Baird K; Delbrook CP; Fleisher TA; Kohler ME; Rampertaap S; Lemberg K; Hurley CK; Kleiner DE; Merchant MS; Pittaluga S; Sabatino M; Stroncek DF; Wayne AS; Zhang H; Fry TJ; Mackall CL
    Blood; 2015 Jan; 125(5):784-92. PubMed ID: 25452614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161.
    Nickoloff BJ; Wrone-Smith T; Bonish B; Porcelli SA
    Arch Dermatol; 1999 May; 135(5):546-52. PubMed ID: 10328195
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Graft-versus-host reactions in the beige mouse. An investigation of the role of host and donor natural killer cells in the pathogenesis of graft-versus-host disease.
    Ghayur T; Seemayer TA; Kongshavn PA; Gartner JG; Lapp WS
    Transplantation; 1987 Aug; 44(2):261-7. PubMed ID: 3307050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: Clinical implications for cancer treatment.
    Oyer JL; Pandey V; Igarashi RY; Somanchi SS; Zakari A; Solh M; Lee DA; Altomare DA; Copik AJ
    Cytotherapy; 2016 May; 18(5):653-63. PubMed ID: 27059202
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-graft-versus-host disease effect of DT390-anti-CD3sFv, a single-chain Fv fusion immunotoxin specifically targeting the CD3 epsilon moiety of the T-cell receptor.
    Vallera DA; Panoskaltsis-Mortari A; Jost C; Ramakrishnan S; Eide CR; Kreitman RJ; Nicholls PJ; Pennell C; Blazar BR
    Blood; 1996 Sep; 88(6):2342-53. PubMed ID: 8822957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Engraftment of human T, B and NK cells in CB.17 SCID/beige mice by transfer of human spleen cells.
    Yacoub-Youssef H; Marcheix B; Calise D; Thiers JC; Therville N; Benoist H; Blaes N; Ségui B; Dambrin C; Thomsen M
    Transpl Immunol; 2005 Dec; 15(2):157-64. PubMed ID: 16412960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Posttransplant Cyclophosphamide and Antithymocyte Globulin versus Posttransplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis for Peripheral Blood Stem Cell Haploidentical Transplants: Comparison of T Cell and NK Effector Reconstitution.
    Makanga DR; Guillaume T; Willem C; Legrand N; Gagne K; Cesbron A; Gendzekhadze K; Peterlin P; Garnier A; Le Bourgeois A; Béné MC; Chevallier P; Retière C
    J Immunol; 2020 Sep; 205(5):1441-1448. PubMed ID: 32747504
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth and activation of natural killer cells ex vivo from children with neuroblastoma for adoptive cell therapy.
    Liu Y; Wu HW; Sheard MA; Sposto R; Somanchi SS; Cooper LJ; Lee DA; Seeger RC
    Clin Cancer Res; 2013 Apr; 19(8):2132-43. PubMed ID: 23378384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phenotype and function of human natural killer cells purified by using a clinical-scale immunomagnetic method.
    Leung W; Iyengar R; Leimig T; Holladay MS; Houston J; Handgretinger R
    Cancer Immunol Immunother; 2005 Apr; 54(4):389-94. PubMed ID: 15449041
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of natural killer cell mediated caspases activation in a graft-versus-host disease model of semiallogeneic small bowel transplantation.
    Fändrich F; Zepernick-Kalinski C; Gebhardt H; Henne-Bruns D; Zavazava N; Lin X
    Transpl Immunol; 1999 Mar; 7(1):1-7. PubMed ID: 10375071
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allogeneic versus syngeneic killer splenocytes as effector cells for the induction of graft-versus-tumor effect.
    Morecki S; Yacovlev E; Gelfand Y; Vilensky A; Slavin S
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):40-8. PubMed ID: 14752778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.